Platinum anticancer drug history
Since 1967, it was discovered that anticancer activity of cisplatin has been, platinum group metals and study the application of anti-cancer drugs has been rapid development. Today, cisplatin and carboplatin in cancer chemotherapy has become the indispensable drug. World Health Organization in 1995, nearly a hundred kinds of anticancer drugs in the world to evaluate the efficacy of cisplatin and market evaluation score among the highest in the column second. According to statistics, China's anti-cancer chemotherapy in the treatment of cisplatin or cisplatin-based participation of all the compatibility of chemotherapy 70% -80%.
Cisplatin and carboplatin's success has greatly encouraged scholars from various countries to study better and more effective new drugs. In the past 30 years, there are thousands of new platinum compounds into the screening, of which 28 compounds in clinical studies, there are four compounds have been approved to enter the market, as well as compounds 2-3 will be production approval.
Platinum anti-cancer drug market sales growing rapidly for decades. 1996, cisplatin and carboplatin has entered the world leader in sales among the top ten anticancer drugs were ranked 8 and 5. Carboplatin in 1999 and entered the world's best-selling non-prescription drugs prior to 15o ranks, ranked 66, and its market potential.
KUNMING GUIYAN PHARMACEUTICAL CO.,LTD.,as holder of the certificate of suitability R0-CEP 2009-383-Rev 00 for CARBOPLATIN.